Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer’s Disease Drug Development

Alzheimer’s disease (AD) is a devastating neurodegenerative disease and the primary cause of dementia worldwide. Despite the magnitude of AD’s impact on patients, caregivers, and society, nearly all AD clinical trials fail. A potential contributor to this high rate of failure is that established cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachman, Shelby L., Blankenship, Jennifer M., Busa, Michael, Serviente, Corinna, Lyden, Kate, Clay, Ieuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578291/
https://www.ncbi.nlm.nih.gov/pubmed/37545234
http://dx.doi.org/10.3233/JAD-230152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578291/
https://www.ncbi.nlm.nih.gov/pubmed/37545234
http://dx.doi.org/10.3233/JAD-230152

Ejemplares similares